Paraproteinaemias and platelet aggregation: role of whole blood aggregometry

Thromb Res. 1989 Jul 15;55(2):267-77. doi: 10.1016/0049-3848(89)90444-1.

Abstract

Whole blood and optical platelet aggregation were measured in normals and in patients with paraproteinaemias; extent of aggregation was correlated with paraprotein concentrations in patients and in normals after addition of different doses of paraproteins; threshold aggregating concentrations of several agonists were also determined in whole blood and in PRP from both groups of subjects. The results indicate that patients with macromolecular monoclonal component bear a "hyperaggregable" state which can be probably ascribed also to plasma hyperviscosity and which is better detected with the impedance aggregometer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Arachidonic Acids / pharmacology
  • Collagen / pharmacology
  • Epinephrine / pharmacology
  • Humans
  • Immunoglobulin Isotypes / analysis
  • In Vitro Techniques
  • Paraproteinemias / blood*
  • Paraproteins / pharmacology
  • Platelet Aggregation / drug effects*

Substances

  • Arachidonic Acids
  • Immunoglobulin Isotypes
  • Paraproteins
  • Adenosine Diphosphate
  • Collagen
  • Epinephrine